Table 3

Per cent of first-time responders* with a ≥30% improvement from baseline in treatment cycles 1–3 for multiple headache symptom measures

≥30% First-time responders, variableOnabotulinumtoxinA (n=688)
Treatment cycle 1Treatment cycle 2Treatment cycle 3
Frequency of headache days, n (%)491 (71.4)65 (9.4)37 (5.4)
Frequency of moderate/severe headache days, n (%)519 (75.4)61 (8.9)30 (4.4)
Total cumulative hours of headache on headache days, n (%)506 (73.5)51 (7.4)42 (6.1)
  • *First-time responders for a given time point are patients who never responded at any previous time points.